Company / Interest Expense
Day One Biopharmaceuticals, Inc. Interest Expense History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$4.7M
FY2022
5-year range
$4.0K / $4.7M
FY2019-FY2022
Trend
+118550.0%
vs FY2021
Sector context
#34 of 42
Health Care
What the data says
Interest Expense changed +118550% YoY in FY2022, a notable deviation from the 3-year average annual change of +39587%.
Based on SEC 10-K filings.
$5M in FY2022.
Increased from -$30,000 to $5M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 42This company $4.7M Sector average $305.3M
▼
-98.4% below sector average
Key checks
Key Insights
- Day One Biopharmaceuticals, Inc.'s interest expense has grown for 3 consecutive years.
- In FY2022, interest expense increased 118550.0% year-over-year.
- Ranks #34 out of 42 companies in the Health Care sector.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $4.7M | +118550.0% |
| FY2021 | $4.0K | +113.3% |
| FY2020 | -$30.0K | +98.6% |
| FY2019 | -$2.1M | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026